Anti-ALPP / alppl2 antibodies, bispecific binding proteins and uses thereof

TW202639605APending Publication Date: 2026-10-01SHANGHAI EPIMAB BIOTHERAPEUTICS CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114145382
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-09
Filing Date
2025-11-20
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078532_001
    Figure TWG2TA001078532_001
  • Figure TWG2TA001078532_002
    Figure TWG2TA001078532_002
  • Figure TWG2TA001078532_003
    Figure TWG2TA001078532_003
Patent Text Reader

Abstract

(ALPPL2), and bispecific binding proteins targeting ALPP / ALPPL2. In addition, the present application further relates to use of said antibodies and bispecific binding proteins, and methods of using said antibodies and bispecific binding proteins for treating diseases or disorders, such as hematopoietic cancers and solid tumors.
Need to check novelty before this filing date? Find Prior Art